- $106.22m
- -$144.61m
- $363.72m
- 86
- 90
- 50
- 89
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 20-F | 20-F | 20-F | 20-F | 20-F |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 181 | 186 | 239 | 341 | 364 |
Cost of Revenue | |||||
Gross Profit | 80.8 | 93.7 | 120 | 141 | 163 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 237 | 206 | 243 | 332 | 365 |
Operating Profit | -56.4 | -19.6 | -4.32 | 9.47 | -1.61 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -48.7 | -13 | 0.983 | 25.4 | 18.4 |
Provision for Income Taxes | |||||
Net Income After Taxes | -53.4 | -14.1 | 1.11 | 21.3 | 14.3 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | -53.2 | -13.8 | 1.19 | 21.5 | 14.2 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -53.2 | -13.8 | 1.19 | 21.5 | 14.2 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.17 | -0.039 | 0.004 | 0.065 | 0.046 |